The FDA says more than 1,600 AI-enabled medical devices had been authorized by September 2026. That makes “we build healthcare AI” a weaker vendor signal, not a stronger one. In medical imaging software development, proof of interoperability, validation, cybersecurity, and regulatory execution now matters more.
How to Evaluate a Medical Imaging Software Development Partner in 2026
Do not hire from a portfolio alone.
A medical imaging product must move large studies reliably, preserve clinical context, integrate with existing systems, protect PHI, and when applicable, produce evidence suitable for regulatory review.
The following ten questions expose whether a vendor can actually do that.
1. Can You Demonstrate Production DICOM and PACS Experience?
Ask for more than “DICOM expertise.”
The engineering team should explain how it has handled:
- DICOM and DICOMweb
- QIDO-RS, WADO-RS, and STOW-RS
- PACS/VNA integration
- modality worklists
- DICOM metadata
- transfer syntaxes
- multi-frame studies
- de-identification
- viewer interoperability
DICOMweb remains the REST-based standard for managing and distributing DICOM objects such as medical images, annotations, and reports.
A qualified medical imaging software development partner should be able to describe real DICOM interoperability problems it has solved, not merely list DICOM as a capability. Ask how the team tests PACS integrations, handles unusual studies, validates metadata, manages failed transfers, and proves compatibility across imaging environments before approving the architecture.
2. How Will You Determine Whether Our Software Is a Medical Device?
This question should come before coding.
FDA treatment depends heavily on intended use and software function. Software that acquires, processes, or analyzes medical images may fall within medical-device oversight rather than qualifying for certain non-device clinical decision-support exclusions.
For software development for medical devices, ask who owns:
- intended-use definition
- software classification
- risk analysis
- design controls
- verification evidence
- regulatory documentation
A vendor that says “HIPAA compliant” but cannot discuss product classification is not answering the regulatory question.
3. How Does Your Development Process Support FDA and QMSR Requirements?
FDA's Quality Management System Regulation became effective February 2, 2026, incorporating ISO 13485:2016 into the device quality framework.
Your medical software development process should therefore make traceability part of delivery, not a documentation sprint before submission.
Ask to see examples of:
- requirements traceability
- risk controls
- verification records
- change management
- defect traceability
- release evidence
Regulatory readiness cannot be added to medical software after engineering is complete. For regulated imaging products, requirements, risks, architecture decisions, tests, defects, releases, and changes should create a traceable evidence chain throughout development. A partner unable to explain that chain can create expensive rework even when the application itself appears functional.
4. How Will You Test Imaging Performance at Clinical Scale?
A demo with ten studies proves almost nothing.
Ask the vendor to define measurable targets for:
| Area | Question to ask |
|---|---|
| Viewer | Time until the first diagnostically useful image appears? |
| Archive | How many studies can be ingested concurrently? |
| Network | What happens on slow hospital connections? |
| Large studies | How are CT/MRI series streamed or prefetched? |
| Recovery | What happens when transfer fails halfway? |
This separates engineering discipline from generic medical software development capability.
5. What Is Your Interoperability Strategy Beyond DICOM?
Medical images rarely operate alone.
Your platform may need RIS, EHR/EMR, identity, scheduling, reporting, billing, or clinical workflow integration using HL7 or FHIR.
Strong healthcare custom software development therefore starts with data flow:
Modality → PACS/VNA → Viewer → Clinical Workflow → EHR → Report
A partner offering mature product engineering services should design those boundaries before feature development accelerates.
6. How Do You Engineer Security Into the Product?
Do not accept “we use encryption.”
Ask about:
- RBAC and least privilege
- MFA
- encryption in transit and at rest
- audit trails
- secrets management
- vulnerability management
- SBOMs
- secure updates
- incident response
- PHI-safe logging
FDA issued updated medical-device cybersecurity guidance in February 2026 covering cybersecurity design and premarket documentation.
Security for medical imaging software is a lifecycle requirement, not an infrastructure checkbox. Buyers should evaluate identity controls, PHI handling, auditability, software dependencies, vulnerability response, secure deployment, update mechanisms, and post-release monitoring. Encryption alone does not demonstrate that a vendor can engineer or maintain a secure medical product.
7. What Is Your Validation Strategy for Imaging AI?
AI integration changes the evaluation.
Ask how the team separates:
- training, validation, and test data
- model version from application version
- inference failures from workflow failures
- model performance from clinical usefulness
- automated output from human review
The FDA's expanding AI-enabled device landscape makes lifecycle control increasingly important.
For AI-assisted products, choose an ai app development company that can discuss model evaluation, observability, rollback, and human oversight, not only model accuracy.
8. Who Owns the Architecture, Data, Models, and IP?
This is where many outsourcing contracts become expensive.
Before selecting among medical software development companies, establish ownership of:
- source code
- infrastructure definitions
- schemas
- trained models
- prompts and evaluation assets
- documentation
- integration adapters
- deployment pipelines
Red flag
If moving to another engineering team would require rebuilding proprietary integration layers, you are buying dependency rather than custom medical software development.
9. What Happens to Our Existing Imaging Platform?
Many organizations do not need a rewrite.
A capable medical software development firm should assess whether components should be retained, wrapped, refactored, migrated, or replaced.
For aging PACS-connected platforms, application modernization services can be more practical than replacing every workflow at once.
Require a migration plan covering parallel operation, DICOM reconciliation, rollback, data verification, and downtime.
10. What Evidence Will You Produce Before We Sign?
Instead of asking, “Have you built healthcare software?” ask for artifacts.
The Quokka Labs Medical Imaging Partner Scorecard
| Proof | Weight |
|---|---|
| DICOM/PACS architecture explanation | 20% |
| Regulatory and validation approach | 20% |
| Security engineering evidence | 15% |
| Interoperability plan | 15% |
| Performance-testing strategy | 10% |
| Migration/rollback plan | 10% |
| IP and handover terms | 10% |
Score vendors against evidence, not sales presentations.
Among top healthcare software development companies, the differentiator should be how clearly engineering decisions can be inspected before development risk becomes contractual risk.
Why Quokka Labs Approaches Imaging as a Product Engineering Problem
Quokka Labs brings 15+ years of custom product engineering experience and reports more than 150 digital products and platforms delivered.
As an AI-native engineering company, we approach medical imaging through architecture, secure data pipelines, product engineering, AI integration, validation, and long-term modernization rather than treating the engagement as isolated feature development.
Projects requiring imaging AI also benefit from disciplined data engineering services around governed datasets and production pipelines.
Final Question: Would You Trust This Partner During an Audit or Production Incident?
That is the real hiring test.
The right provider of medical device software development services should explain what happens when a PACS rejects studies, an AI model changes, a vulnerability appears, validation fails, or a regulator asks for evidence.
Medical imaging software development is not won by the vendor with the longest capability list.
It is won by the team that can prove how the system will work, fail safely, recover, integrate, and remain auditable.
Planning a medical imaging platform, AI workflow, or modernization program? Explore Quokka Labs’ Ai Native Engineering services and evaluate the architecture before committing engineering budget.
Top comments (0)